A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages

  Myrehaug, Sten ^a,b   Chan, Gordon ^a   Craig, Tim ^b   Weinberg, Vivian ^c   Cheng, Chun ^a   Roach III, MacK ^d   Cheung, Patrick ^a   Sahgal, Arjun ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute toxicity; Dosimetric comparison; Intensity modulated radiotherapy; Prostate cancer; Volumetric modulated radiotherapy

Indexed keywords

ACUTE TOXICITY; AFTER-TREATMENT; CLINICAL TRIAL; DOSIMETRIC COMPARISON; GASTROINTESTINAL TOXICITIES; INTENSITY-MODULATED RADIOTHERAPY; LYMPH NODE; ORGANS AT RISKS; PELVIC LYMPH NODES; PLANNING TARGET VOLUMES; PROSTATE CANCERS; RADIATION THERAPY ONCOLOGY GROUPS; SEMINAL VESICLE; SIMULTANEOUS INTEGRATED BOOSTS; TOTAL DOSE; TREATMENT PLANNING; TREATMENT PLANS; TREATMENT TIME; VOLUMETRIC MODULATED ARC THERAPY;

BODY FLUIDS; DISEASES; DOSIMETERS; DOSIMETRY; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; TOXICITY; UROLOGY;

PHYSICAL THERAPY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CYSTITIS; DIARRHEA; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; TREATMENT PLANNING; URINARY FREQUENCY; URINARY HESITANCY; URINARY URGENCY; URINE RETENTION; UROGENITAL TRACT DISEASE; VOLUMETRIC MODULATED ARC THERAPY;

AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; GUIDELINE ADHERENCE; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; NANOPARTICLES; ORGANS AT RISK; PELVIS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RETROSPECTIVE STUDIES; RISK; TUMOR BURDEN; URINARY BLADDER;

EID: 84857919323     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.006     Document Type: Article

References (20)

1. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial Lancet 360 2002 103 106
2. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
3. C.R. King, and J.F. Fowler A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low Int J Radiat Oncol Biol Phys 51 2001 213 214
4. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
5. G. Arcangeli, B. Saracino, and S. Gomellini A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer Int J Radiat Oncol Biol Phys 78 2010 11 18
6. D. Norkus, A. Miller, and J. Kurtinaitis A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma: A report on acute toxicity Strahlenther Onkol 185 2009 715 721
7. M. Roach 3rd, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
8. H.A. Shih, M. Harisinghani, and A.L. Zietman Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy Int J Radiat Oncol Biol Phys 63 2005 1262 1269
9. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
10. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
11. Quon H, Cheung PC, Loblaw DA, et al. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: Late toxicity. Int J Radiat Oncol Biol Phys 2011. In press.
12. C.A. Lawton, J. Michalski, and I. El-Naqa Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 74 2009 377 382
13. C. Fiorino, F. Alongi, and L. Perna Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer Int J Radiat Oncol Biol Phys 75 2009 29 35
14. C. Fiorino, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: Pelvis Radiother Oncol 93 2009 153 167
15. B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 2010 S101 S107
16. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
17. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
18. K. Otto Volumetric modulated arc therapy: IMRT in a single gantry arc Med Phys 35 2008 310 317
19. M. Guckenberger, A. Richter, and T. Krieger Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol 93 2009 259 265
20. S. Yoo, Q.J. Wu, and W.R. Lee Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes Int J Radiat Oncol Biol Phys 76 2010 935 942